Tag: pharmaceuticals
-
Challenge Seeks Reliable Depression Diagnostics, Models
A new competition seeks reliable biological methods for detecting depression and decision models that connect diagnostics to effective disease treatments.
-
FDA Okays Trial of Donated Stem Cells for Parkinson’s
An organization studying stem cell therapies says it received FDA authorization for a clinical trial to test donated stem cells to treat Parkinson’s disease.
-
Patent Awarded for Safer Cancer Drug Delivery
A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients.
-
Antibodies Help Some Hospitalized Covid-19 Patients
Results from a clinical trial show a combination of two synthetic antibodies reduces deaths in hospitalized Covid-19 patients with no earlier immune response.
-
Biotechs Partner on Crispr Therapies for Neuro Disorders
Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS.
-
U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal
Two U.S. government health agencies agreed to purchase some 1.7 million doses of a Covid-19 antiviral drug, once the drug receives clearance from FDA.
-
FDA Okays Lower Dose, Injected Covid-19 Antibodies
The Food and Drug Administration updated its emergency authorization for a dual-antibody Covid-19 therapy to allow for a lower and injectable dose.
-
Low Cost Vaccine, Patch Device Produce Immune Responses
Tests with lab mice show one dose of a lower cost Covid-19 vaccine given with a needle-free patch generates strong antibody and cellular immune responses.
-
Trade, Finance, Health Groups Urge Vaccine Boost
The leaders of four international economic and health organizations call for a $50 billion investment to ensure faster vaccinations in all parts of the world.
-
Infographic – U.S. Kids Vaccine Status Matches Parents
Findings from the YouGov poll show the likelihood of children in the U.S. getting a Covid-19 vaccine depends largely on their parents’ vaccination status or plans.